- Home
- CDIO vs GIPR Comparison
CDIO vs GIPR Comparison
Compare CDIO & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- GIPR
- Stock Information
- Founded
- CDIO 2017
- GIPR 2015
- Country
- CDIO United States
- GIPR United States
- Employees
- CDIO N/A
- GIPR N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- GIPR Real Estate Investment Trusts
- Sector
- CDIO Health Care
- GIPR Real Estate
- Exchange
- CDIO Nasdaq
- GIPR Nasdaq
- Market Cap
- CDIO 6.4M
- GIPR 5.1M
- IPO Year
- CDIO N/A
- GIPR 2021
- Fundamental
- Price
- CDIO $3.86
- GIPR $1.07
- Analyst Decision
- CDIO
- GIPR
- Analyst Count
- CDIO 0
- GIPR 0
- Target Price
- CDIO N/A
- GIPR N/A
- AVG Volume (30 Days)
- CDIO 21.5K
- GIPR 358.4K
- Earning Date
- CDIO 11-12-2025
- GIPR 11-14-2025
- Dividend Yield
- CDIO N/A
- GIPR N/A
- EPS Growth
- CDIO N/A
- GIPR N/A
- EPS
- CDIO N/A
- GIPR N/A
- Revenue
- CDIO $19,507.00
- GIPR $9,884,093.00
- Revenue This Year
- CDIO $1,434.82
- GIPR N/A
- Revenue Next Year
- CDIO $4,661.91
- GIPR N/A
- P/E Ratio
- CDIO N/A
- GIPR N/A
- Revenue Growth
- CDIO N/A
- GIPR 2.33
- 52 Week Low
- CDIO $3.22
- GIPR $0.78
- 52 Week High
- CDIO $53.10
- GIPR $2.44
- Technical
- Relative Strength Index (RSI)
- CDIO 51.46
- GIPR 55.03
- Support Level
- CDIO $3.58
- GIPR $0.88
- Resistance Level
- CDIO $3.98
- GIPR $1.18
- Average True Range (ATR)
- CDIO 0.23
- GIPR 0.10
- MACD
- CDIO 0.03
- GIPR 0.03
- Stochastic Oscillator
- CDIO 66.67
- GIPR 63.33
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.